GSK3B and Parkinson disease: Additionally, OCN was shown to reduce apoptosis of dopaminergic neurons in PD mouse models, alleviate neurotoxicity, and improve motor function impairments by modulating the Akt/glycogen synthase kinase 3beta (GSK3β) signaling pathway (Hou et al., 2021).